GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $16,000 | 0.0% | 365 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $16,000 | 0.0% | 365 | 0.0% | 0.01% | -16.7% |
| Q4 2021 | $16,000 | +14.3% | 365 | 0.0% | 0.01% | +20.0% |
| Q3 2021 | $14,000 | +7.7% | 365 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $13,000 | -45.8% | 365 | -39.5% | 0.01% | -60.0% |
| Q2 2019 | $24,000 | -4.0% | 603 | 0.0% | 0.02% | -11.8% |
| Q1 2019 | $25,000 | -44.4% | 603 | -48.8% | 0.02% | -50.0% |
| Q4 2018 | $45,000 | -25.0% | 1,178 | -21.6% | 0.03% | -15.0% |
| Q3 2018 | $60,000 | -9.1% | 1,503 | -7.7% | 0.04% | -13.0% |
| Q2 2018 | $66,000 | +3.1% | 1,628 | 0.0% | 0.05% | +9.5% |
| Q1 2018 | $64,000 | -33.3% | 1,628 | -37.1% | 0.04% | -28.8% |
| Q4 2017 | $96,000 | -50.0% | 2,588 | -45.3% | 0.06% | -53.9% |
| Q3 2017 | $192,000 | -5.9% | 4,728 | 0.0% | 0.13% | -7.2% |
| Q2 2017 | $204,000 | -1.9% | 4,728 | -4.1% | 0.14% | -7.4% |
| Q1 2017 | $208,000 | +6.7% | 4,928 | -2.6% | 0.15% | +4.2% |
| Q4 2016 | $195,000 | – | 5,058 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |